Delivery Order SPE2DB25D3404-SPE2DB25FUQFB
Award Date 9/5/25
Potential Completion Date 9/26/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $85,300.56 to AmerisourceBergen Drug Corp for TAGRISSO 80 mg tablets (30-count units) on August 4, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. TAGRISSO is an oncology medication used for treating certain types of lung cancer,...
- The Defense Logistics Agency awarded a delivery order valued at $31,923.21 to AmerisourceBergen Drug Corp for TAGRISSO 40 mg tablets (30-count packages) on September 9, 2025, with completion expected by September 30, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. TAGRISSO is a prescription oncology medication, and this procurement supports the...
- The Defense Logistics Agency awarded a $31,892.74 delivery order to AmerisourceBergen Drug Corp for TAGRISSO (80 mg tablets, 30-count package) under a firm fixed-price contract type. The award was issued on September 17, 2025, with an ultimate completion date of October 8, 2025, and represents a competitively awarded non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order, leveraging its established...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TAGRISSO 80 MG tablets in the amount of $10,662.57 on September 26, 2025. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 20, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. TAGRISSO is a prescription oncology medication used to treat certain types of lung cancer, reflecting the critical pharmaceutical products supplied...
- The Defense Logistics Agency awarded a delivery order valued at $10,641.07 to AmerisourceBergen Drug Corp for the supply of TAGRISSO 40 mg tablets (30-count units) on April 24, 2025. This competitively awarded, firm fixed price delivery order is scheduled for completion by May 15, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $21,325.14 for TAGRISSO 80 mg tablets (30-count units) on July 31, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price, competitively awarded delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TAGRISSO is a prescription oncology medication used primarily in the treatment of...
- The Defense Logistics Agency awarded a $10,662.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of TAGRISSO 80 MG tablets (30-count) under a competitively awarded contract with no set-aside designation. The delivery order was awarded on August 12, 2025, with an ultimate completion date of September 3, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. TAGRISSO is a prescription oncology medication, and this delivery order...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on September 18, 2025, for TAGRISSO 80 mg tablets (30-count units) with a ceiling value of $10,662.57. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of TAGRISSO 80 mg tablets in a quantity of 30 units. This is a firm fixed-price contract with a ceiling value of $159,938.55 and an ultimate completion date of October 16, 2025. The contract is not set-aside and was competitively awarded to the prime contractor, whose corporate office is located in Conshohocken, Pennsylvania. TAGRISSO is a prescription...
- The Defense Logistics Agency awarded a delivery order valued at $10,662.57 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count packages). This competitive award, issued on August 12, 2025, with an ultimate completion date of September 3, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance of this contract will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Tagrisso is a...